Literature DB >> 29292607

OPTN/SRTR 2016 Annual Data Report: Economics.

M A Schnitzler1,2, M A Skeans1, D A Axelrod3, K L Lentine2, H B Randall2, J J Snyder1,4, A K Israni1,4,5, B L Kasiske1,5.   

Abstract

Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per-person per-year reimbursement was $75 thousand for kidney recipients who survived the first year posttransplant with a functioning graft, $171 thousand for those who required a return to dialysis or retransplant, and $350 thousand for those who died with function. For pancreas recipients: $105 thousand for those who survived the first year with a functioning graft, $120 thousand for those who survived pancreas failure, and $443 thousand for those who died with function. For liver recipients: $154 thousand for those who survived with a functioning graft, $388 thousand for those who required retransplant, and $740 thousand who died with function. For intestine recipients: $301 thousand for those who survived with a functioning graft and $1 million for those who died with function. For heart recipients: $272 thousand for those who survived with a functioning graft and $1.2 million for those who died with function. For lung recipients: $196 thousand for those who survived with a functioning graft, $642 thousand for those who required retransplant, and $761 thousand for those who died with function. .

Entities:  

Keywords:  Cost-benefit analysis; Medicare; costs and cost analysis; health expenditures

Mesh:

Year:  2018        PMID: 29292607     DOI: 10.1111/ajt.14564

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.

Authors:  Matthew Kadatz; John S Gill; Jagbir Gill; Richard N Formica; Scott Klarenbach
Journal:  J Am Soc Nephrol       Date:  2019-11-08       Impact factor: 10.121

2.  Expanding analytic possibilities in pediatric solid organ transplantation through linkage of administrative and clinical registry databases.

Authors:  Justin Godown; Matt Hall; Bryn Thompson; Cary Thurm; Kathy Jabs; Lynette A Gillis; Einar T Hafberg; Sophoclis Alexopoulos; Seth J Karp; Jonathan H Soslow
Journal:  Pediatr Transplant       Date:  2019-02-21

3.  Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.

Authors:  Yasar Caliskan; Brian Lee; Adrian Whelan; Fadee Abualrub; Krista L Lentine; Arksarapuk Jittirat
Journal:  Curr Transplant Rep       Date:  2022-03-16

4.  Billing for living kidney donor care: Balancing cost recovery, regulatory compliance, and minimized donor burden.

Authors:  Andrea Tietjen; Rebecca Hays; Gwen McNatt; Robert Howey; Ursula Lebron-Banks; Christie P Thomas; Krista L Lentine
Journal:  Curr Transplant Rep       Date:  2019-04-27

Review 5.  Evaluation and care of international living kidney donor candidates: Strategies for addressing common considerations and challenges.

Authors:  Ellen Shukhman; Julia Hunt; Dianne LaPointe-Rudow; Didier Mandelbrot; Rebecca E Hays; Vineeta Kumar; Heidi Schaefer; Fawaz Al Ammary; Macey L Henderson; Angie Nishio-Lucar; Matthew Cooper; Krista L Lentine
Journal:  Clin Transplant       Date:  2020-02-29       Impact factor: 2.863

6.  Primacy in Kidney Allocation: Does It Alleviate the Barriers to Transplantation?

Authors:  John S Gill; Catherine R Butler; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2021-06-17       Impact factor: 14.978

7.  Facial Transplantation in a Nationalized Health System: The Canadian Experience.

Authors:  Etienne Lorquet; Alexander Govshievich; André Chollet; Dominique M Tremblay; Daniel E Borsuk
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.